hypertensive intracerebral hemorrhage
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. From January 1, 2020 to June 30, 2022, who was admitted to the neurosurgery department for treatment; 2. Aged >= 18 years old; 3. The patients were diagnosed with hypertensive cerebral hemorrhage, cerebral hemorrhage, basal ganglia hemorrhage, intracranial hemorrhage, and subarachnoid hemorrhage; 4. Surgical procedures included intracerebral hematoma removal, intracranial hematoma removal, intracerebral hematoma drainage, and endoscopic intracerebral hematoma drainage; 5. The approach is endoscopy.
Exclusion criteria
Exclusion criteria: 1. Patients with non-anticipated massive hemorrhage were excluded; 2. Exclude patients whose total medical expenses are extreme due to long-term hospitalization due to coma; 3. If the central doctor judges that the patient is not suitable to participate in other conditions, he will not be included in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hematoma clearance rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence of postoperative edema;Incidence of postoperative rebleeding;Intraoperative bleeding volume;Blood transfusion rate;Rate of cranial drainage tube placement;Incidence of serious postoperative complications;Rate of secondary surgery; | — |
Countries
China
Contacts
The First Affiliated Hospital of Nanchang University